Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro



Kathirvel, Kandasamy, Karen, Lester, Haribalaganesh, Ravinarayanan, Krishnadas, Ramasamy, Muthukkaruppan, Veerappan, Lane, Brian, Simpson, David A, Goljanek-Whysall, Kasia ORCID: 0000-0001-8166-8800, Sheridan, Carl ORCID: 0000-0003-0100-9587, Bharanidharan, Devarajan
et al (show 2 more authors) (2022) Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro SCIENTIFIC REPORTS, 12 (1). 8299-. ISSN 2045-2322, 2045-2322

[thumbnail of Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro.pdf] Text
Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro.pdf - Published version

Download (1MB) | Preview

Abstract

In the quest of identifying newer molecular targets for the management of glucocorticoid-induced ocular hypertension (GC-OHT) and glaucoma (GCG), several microarray studies have attempted to investigate the genome-wide transcriptome profiling of primary human trabecular meshwork (TM) cells in response to dexamethasone (DEX). However, no studies are reported so far to demonstrate the temporal changes in the expression of genes in the cultured human TM cells in response to DEX treatment. Therefore, in the present study, the time-dependent changes in the genome-wide expression of genes in primary human TM cells after short (16 hours: 16 h) and long exposure (7 days: 7 d) of DEX was investigated using RNA sequencing. There were 199 (118 up-regulated; 81 down-regulated) and 525 (119 up-regulated; 406 down-regulated) DEGs in 16 h and 7 d treatment groups respectively. The unique genes identified in 16 h and 7 d treatment groups were 152 and 478 respectively. This study found a distinct gene signature and pathways between two treatment regimes. Longer exposure of DEX treatment showed a dys-regulation of Wnt and Rap1 signaling and so highlighted potential therapeutic targets for pharmacological management of GC-OHT/glaucoma.

Item Type: Article
Uncontrolled Keywords: Trabecular Meshwork, Cells, Cultured, Humans, Glaucoma, Dexamethasone, Glucocorticoids, Transcriptome
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Life Courses & Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 07 Jun 2022 13:12
Last Modified: 16 Jun 2026 11:19
DOI: 10.1038/s41598-022-12443-7
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3156009
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.